A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

Clinical trial NCT04449276 · COMPLETED

Trial details

NCT number: NCT04449276
Sponsor: CureVac
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2 COVID-19

Start date: 2020-06-18
Primary completion: 2021-12-21
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.